BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1535 related articles for article (PubMed ID: 34237774)

  • 1. Mapping the human genetic architecture of COVID-19.
    COVID-19 Host Genetics Initiative
    Nature; 2021 Dec; 600(7889):472-477. PubMed ID: 34237774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the genetic relationship between gastro-esophageal reflux disease and risk of COVID-19 infection.
    Ong JS; Gharahkhani P; Vaughan TL; Whiteman D; Kendall BJ; MacGregor S
    Hum Mol Genet; 2022 Feb; 31(3):471-480. PubMed ID: 34553760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
    Li GH; Tang CM; Cheung CL
    Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
    COVID-19 Host Genetics Initiative
    Eur J Hum Genet; 2020 Jun; 28(6):715-718. PubMed ID: 32404885
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
    PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption.
    Rao S; Baranova A; Cao H; Chen J; Zhang X; Zhang F
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34308962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.
    Debnath M; Banerjee M; Berk M
    FASEB J; 2020 Jul; 34(7):8787-8795. PubMed ID: 32525600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study.
    Au Yeung SL; Zhao JV; Schooling CM
    BMC Med; 2021 Mar; 19(1):72. PubMed ID: 33757497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing reveals host factors underlying critical COVID-19.
    Kousathanas A; Pairo-Castineira E; Rawlik K; Stuckey A; Odhams CA; Walker S; Russell CD; Malinauskas T; Wu Y; Millar J; Shen X; Elliott KS; Griffiths F; Oosthuyzen W; Morrice K; Keating S; Wang B; Rhodes D; Klaric L; Zechner M; Parkinson N; Siddiq A; Goddard P; Donovan S; Maslove D; Nichol A; Semple MG; Zainy T; Maleady-Crowe F; Todd L; Salehi S; Knight J; Elgar G; Chan G; Arumugam P; Patch C; Rendon A; Bentley D; Kingsley C; Kosmicki JA; Horowitz JE; Baras A; Abecasis GR; Ferreira MAR; Justice A; Mirshahi T; Oetjens M; Rader DJ; Ritchie MD; Verma A; Fowler TA; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Elliott P; Walsh T; Tenesa A; ; ; ; Fawkes A; Murphy L; Rowan K; Ponting CP; Vitart V; Wilson JF; Yang J; Bretherick AD; Scott RH; Hendry SC; Moutsianas L; Law A; Caulfield MJ; Baillie JK
    Nature; 2022 Jul; 607(7917):97-103. PubMed ID: 35255492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    Leong A; Cole JB; Brenner LN; Meigs JB; Florez JC; Mercader JM
    PLoS Med; 2021 Mar; 18(3):e1003553. PubMed ID: 33661905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Elhabyan A; Elyaacoub S; Sanad E; Abukhadra A; Elhabyan A; Dinu V
    Virus Res; 2020 Nov; 289():198163. PubMed ID: 32918943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study.
    Li S; Hua X
    BMC Med Genomics; 2021 Feb; 14(1):38. PubMed ID: 33536004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
    Freuer D; Linseisen J; Meisinger C
    Metabolism; 2021 May; 118():154732. PubMed ID: 33631142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity.
    Karaderi T; Bareke H; Kunter I; Seytanoglu A; Cagnan I; Balci D; Barin B; Hocaoglu MB; Rahmioglu N; Asilmaz E; Taneri B
    Front Immunol; 2020; 11():586111. PubMed ID: 33414783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
    Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
    [No Abstract]   [Full Text] [Related]  

  • 19. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
    Wang L; Balmat TJ; Antonia AL; Constantine FJ; Henao R; Burke TW; Ingham A; McClain MT; Tsalik EL; Ko ER; Ginsburg GS; DeLong MR; Shen X; Woods CW; Hauser ER; Ko DC
    Genome Med; 2021 May; 13(1):83. PubMed ID: 34001247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility to severe COVID-19.
    Cappadona C; Rimoldi V; Paraboschi EM; Asselta R
    Infect Genet Evol; 2023 Jun; 110():105426. PubMed ID: 36934789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.